These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10396495)

  • 1. Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine.
    Paunio M; Peltola H; Valle M; Davidkin I; Virtanen M; Heinonen OP
    J Epidemiol Community Health; 1999 Mar; 53(3):173-8. PubMed ID: 10396495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles outbreak in 31 schools: risk factors for vaccine failure and evaluation of a selective revaccination strategy.
    Yuan L
    CMAJ; 1994 Apr; 150(7):1093-8. PubMed ID: 8137189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Explosive school-based measles outbreak: intense exposure may have resulted in high risk, even among revaccinees.
    Paunio M; Peltola H; Valle M; Davidkin I; Virtanen M; Heinonen OP
    Am J Epidemiol; 1998 Dec; 148(11):1103-10. PubMed ID: 9850133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age.
    Aaby P; Andersen M; Sodemann M; Jakobsen M; Gomes J; Fernandes M
    BMJ; 1993 Nov; 307(6915):1308-11. PubMed ID: 8257884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A school-based measles outbreak: the effect of a selective revaccination policy and risk factors for vaccine failure.
    Hutchins SS; Markowitz LE; Mead P; Mixon D; Sheline J; Greenberg N; Preblud SR; Orenstein WA; Hull HF
    Am J Epidemiol; 1990 Jul; 132(1):157-68. PubMed ID: 2356806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles vaccine efficacy during an outbreak in a highly vaccinated population: incremental increase in protection with age at vaccination up to 18 months.
    De Serres G; Boulianne N; Meyer F; Ward BJ
    Epidemiol Infect; 1995 Oct; 115(2):315-23. PubMed ID: 7589271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of vaccination at 6 to 11 months of age during an outbreak of measles.
    de Serres G; Boulianne N; Ratnam S; Corriveau A
    Pediatrics; 1996 Feb; 97(2):232-5. PubMed ID: 8584383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a measles vaccine efficacy during a measles outbreak in Mbare, City of Harare Zimbabwe.
    Mahomva AI; Moyo IM; Mbengeranwa LO
    Cent Afr J Med; 1997 Sep; 43(9):254-6. PubMed ID: 9509644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for measles and vaccine efficacy during an epidemic in Montreal.
    Rivest P; Bédard L; Arruda H; Trudeau G; Remis RS
    Can J Public Health; 1995; 86(2):86-90. PubMed ID: 7757898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles epidemic in the Netherlands, 1999-2000.
    van den Hof S; Conyn-van Spaendonck MA; van Steenbergen JE
    J Infect Dis; 2002 Nov; 186(10):1483-6. PubMed ID: 12404165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles vaccine efficacy in children previously vaccinated at 12 months of age.
    Marks JS; Halpin TJ; Orenstein WA
    Pediatrics; 1978 Dec; 62(6):955-60. PubMed ID: 733423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12-14 months versus 15 months of age.
    De Serres G; Boulianne N; Defay F; Brousseau N; Benoît M; Lacoursière S; Guillemette F; Soto J; Ouakki M; Ward BJ; Skowronski DM
    Clin Infect Dis; 2012 Aug; 55(3):394-402. PubMed ID: 22543023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outbreak of measles in a highly vaccinated secondary school population.
    Sutcliffe PA; Rea E
    CMAJ; 1996 Nov; 155(10):1407-13. PubMed ID: 8943928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revaccination of children during school-based measles outbreaks: potential impact of a new policy recommendation.
    Osterman JW; Melnychuk D
    CMAJ; 1992 Mar; 146(6):929-36. PubMed ID: 1544080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measles epidemic in the Netherlands, 1999-2000].
    van den Hof S; van den Kerkhof JH; ten Ham PB; van Binnendijk RS; Conyn-van Spaendonck MA; van Steenbergen JE
    Ned Tijdschr Geneeskd; 2001 Dec; 145(52):2529-33. PubMed ID: 11793829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Measles in Poland in 2002].
    Czarkowski MP; Kondej B
    Przegl Epidemiol; 2004; 58(1):21-7. PubMed ID: 15218638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles in children vaccinated with 2 doses of MMR.
    Defay F; De Serres G; Skowronski DM; Boulianne N; Ouakki M; Landry M; Brousseau N; Ward BJ
    Pediatrics; 2013 Nov; 132(5):e1126-33. PubMed ID: 24144708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for measles in children aged 8 months-14 years in China after nationwide measles campaign: A multi-site case-control study, 2012-2013.
    Hao L; Ma C; Wannemuehler KA; Su Q; An Z; Cairns L; Quick L; Rodewald L; Liu Y; He H; Xu Q; Ma Y; Yu W; Zhang N; Li L; Wang N; Luo H; Wang H; Gregory CJ
    Vaccine; 2016 Dec; 34(51):6545-6552. PubMed ID: 26876440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are vaccinated measles cases protected against severe disease?
    Bonneton M; Antona D; Danis K; Aït-Belghiti F; Levy-Bruhl D
    Vaccine; 2020 Jun; 38(29):4516-4519. PubMed ID: 32418790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.